Abbott Laboratories' stock took a direct hit, wiping out nearly 10% of its market value following its Q4 earnings. Response? The CEO bought $2 million shares. Robert B. Ford, CEO of Abbott ...

Robert Ford, Abbott Laboratories chairman and CEO, joins 'Squawk Box' to discuss the state of healthcare demand, the company's nutrition business, growth outlook, and more. Got a confidential news tip ...

) is bracing for the impact of higher tariffs, including a 50% US levy on its Indian imports. "Our impact between the whole network is just under $200 million," CEO Robert Ford said on Yahoo Finance's ...

Wall Street still prices Abbott like a dividend stalwart, but overlooked moves suggest that framing may be costing investors ...